I definitely agree with you. If EXEL were a larger company, they would have worked out a narrower range of CABO dosages before proceeding. As a small company, EXEL didn't have the luxury of time.
For once I made buys and the stocks didn't to go. I bought more EXEL about a week ago at $5 and more MNTA at $15. Maybe this is a new year after all.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.